If the Cardinals are going to make a deep playoff run it sounds like it will have to be without shortstop Rafael Furcal and probably without first baseman Lance Berkman too.
General manager John Mozeliak was pessimistic about the chances of either player returning from injury this season and in fact Joe Strauss of the St. Louis Post Dispatch writes that he “all but extinguished hope” for Furcal’s return.
“The clock’s not on our side,” Mozeliak said about Furcal, who hasn’t played since injuring his elbow on August 30 and may eventually need surgery that comes with a six-month recovery timetable.
Berkman’s odds of returning are better, but Strauss reports that he’s yet to swing a bat since undergoing a second knee surgery and has toned down his recent optimism about potentially coming back.
MLB.com’s Brian McTaggart reports that Astros first baseman Jonathan Singleton has been suspended 100 games after testing positive for a drug of abuse for a third time. Minor league pitcher Dean Deetz has been suspended 80 games after testing positive for Dehydroclormethyltestosterone.
Singleton, 26, has had issues with marijuana in the past and opened up about his addiction several years ago. He said, “At this point it’s pretty evident to me that I’m a drug addict. I don’t openly tell everyone that, but it’s pretty apparent to myself.” He added, “I know that I enjoy smoking weed, I enjoy being high and I can’t block that out of my mind that I enjoy that. So I have to work against that.”
Singleton hasn’t played in the majors since 2015. Last season, after going all the way back to Double-A Corpus Christi, he hit .205/.376/.397 with 18 home runs and 62 RBI in 500 plate appearances.
Deetz, 24, was selected by the Astros in the 11th round of the 2014 draft. Between Corpus Christi and Triple-A Fresno last season, the right-hander posted a 4.25 ERA with a 97/50 K/BB ratio in 84 2/3 innings of work. He denies knowingly using a PED, per ESPN’s Keith Law.